FORCE MAJEURE

This blog is one-part nostalgia and one-part cautionary tale. Take it with a grain of salt…but do not take it for granted. I recently completed a project wherein I assisted…

Read more »

R&D CREDITS… DON’T LET YOUR RESEARCH AND DEVELOPMENT COSTS FOR PHARMACEUTICAL AND DIAGNOSTIC TECHNOLOGIES SIT ON THE SHELF WHEN YOU CAN TURN THEM INTO CASH FLOW

When  developing a new pharmaceutical or diagnostic equipment,  companies typically incur substantial costs for salaries, supplies, laboratory, contractors  and a myriad other expenses..    While deductible, these costs may not benefit…

Read more »

NEW LEASE ACCOUNTING STANDARDS CURFEW DECEMBER 31… DO YOU KNOW WHERE YOUR BALANCE SHEET IS?

Lease accounting to comply with new Accounting Standards Update (ASU) under FASB 842(US) and IFRS 16(European) is about to change in fundamental ways not seen in decades. First to be…

Read more »

HOW COST SEGREGATION CAN IMPROVE ROI ON YOUR HEALTHCARE FACILITY

Owners/operators of healthcare facilities (laboratories, physician offices, assisted living and long-term care facilities) must continually be adding new or improving existing facilities to keep up with growth, changing technologies and patient needs….

Read more »

SURVIVING M&A DUE DILIGENCE

You may remember the commercial when a camera catches a winning Super Bowl player who proclaims “I’m going to Disney World”. Well, Mr. or Ms. Business owner, you have just…

Read more »

THE LIFE SCIENCE BLOG SERIES NO. 1: USING VENTURE DEBT EFFECTIVELY

Growing life science companies seeking to raise capital face a wide range of options, structures, and considerations. Early Stage Friends and family, angel investors, and even some venture capital firms…

Read more »